eGenesis bets on CRISPR to domesticate pig organs for safer xenotransplantation – MedCity News
MedCity News |
eGenesis bets on CRISPR to domesticate pig organs for safer xenotransplantation
MedCity News Boston-based eGenesis recently received $38 million in Series A financing to develop a safer xenotransplant. Founded by research superstar and serial entrepreneur George Church and former Church lab scientist Luhan Yang, the company is using CRISPR … Can pigs solve our organ transplant shortage with help from CRISPR? |
